Dr Mary Carol Sims, MD | |
140 Weasel Creek Rd, Box 470126, Winston, MT 59647-0126 | |
(406) 992-0195 | |
(866) 349-6549 |
Full Name | Dr Mary Carol Sims |
---|---|
Gender | Female |
Speciality | Psychiatry & Neurology - Neurology |
Location | 140 Weasel Creek Rd, Winston, Montana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114114220 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084N0400X | Psychiatry & Neurology - Neurology | 8758 (Montana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Mary Carol Sims, MD Po Box 470126, 140 Weasel Creek Rd, Winston, MT 59647-0126 Ph: (406) 992-0195 | Dr Mary Carol Sims, MD 140 Weasel Creek Rd, Box 470126, Winston, MT 59647-0126 Ph: (406) 992-0195 |
News Archive
Longtime environmental health researchers at Tufts University School of Medicine describe the carcinogenic effects of endocrine-disrupting chemicals, ubiquitous chemicals that have hormone-like effects in the body. In a review article published online May 25 in Nature Reviews Endocrinology, the researchers express the need for more complex strategies for studying how these chemicals affect health but report that ample evidence already supports changing public health and environmental policies to protect the public from exposure to EDCs.
Impact Advisors, LLC, a leading provider of healthcare information technology services, is pleased to announce that it has been selected, for the sixth consecutive year, as one of Modern Healthcare's Best Places to Work in Healthcare. Specific rankings will be revealed during Modern Healthcare's awards gala in Nashville on October 14.
By picking Paul Ryan as his running mate, Mitt Romney introduced Medicare into his campaign for the presidency. Veterans of the entitlement wars immediately said that in doing so Gov. Romney was suiciding his candidacy.
If you have a relative with cancer, probably one of the most pressing questions is what your chances are of getting it yourself. In a paper published in PloS Medicine, the premier medical journal freely available online, Laufey Amundadottir and colleagues from deCODE genetics (a company that is using genetics to develop new drug treatments) and Iceland's National-University Hospital go some way toward answering that question.
With the launch of the Caya contoured diaphragm this June, women in the United States will have access to a method of contraception that is nonhormonal, has few side effects, and can be used for up to two years. Last fall, the United States Food and Drug Administration cleared the single-size Caya contoured diaphragm for marketing in the US, and now the diaphragm is available by prescription from healthcare providers.
› Verified 3 days ago